Identification and characterization of human ribokinase and comparison of its properties with E. coli ribokinase and human adenosine kinase  by Park, Jae et al.
FEBS Letters 581 (2007) 3211–3216Identiﬁcation and characterization of human ribokinase and
comparison of its properties with E. coli ribokinase and
human adenosine kinase
Jae Park, Paul van Koeverden, Bhag Singh, Radhey S. Gupta*
Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada L8N 3Z5
Received 26 April 2007; revised 25 May 2007; accepted 8 June 2007
Available online 15 June 2007
Edited by Judit Ova´diAbstract The gene responsible for ribokinase (RK) in human/
eukaryotic cells has not yet been identiﬁed/characterized. Blast
searches with E. coli RK have identiﬁed a human protein showing
signiﬁcant similarity to the bacterial RK. The cDNA for this
protein was expressed in E. coli and the recombinant protein eﬃ-
ciently phosphorylated ribose to ribose-5-phosphate using ATP,
conﬁrming its identity as RK. In contrast to ribose, the enzyme
exhibited very little to no phosphorylation of D-arabinose,
D-xylose, D-fructose and D-galactose. The catalytic activity of
human RK was dependent upon the presence of inorganic phos-
phate, as observed previously for E. coli RK and mammalian
adenosine kinases (AK). A number of activators and inhibitors
of human AK, produced very similar eﬀects on the human and
E. coli RKs, indicating that the catalytic mechanism of RK is
very similar to that of the AKs.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Ribokinase is a carbohydrate kinase, which catalyzes the
phosphorylation of ribose to ribose-5-phosphate (R-5-P).
Exogenous ribose has shown beneﬁcial eﬀects in a number of
studies. It has been reported to enhance cardiac and muscular
performance and to accelerate the repletion of ATP in rat and
canine myocardium as well as in isolated cardiomyocytes and
endothelial cells [1–4]. Ribose addition also helps maintain
higher levels of ATP in rat heart and dog kidney during trans-
plantation experiments [5], and it led to improvement of neu-
rological symptoms in a patient with adenylosuccinase
deﬁciency [6]. In order for ribose to be incorporated into
ATP or other high energy phosphorylated derivatives, ribose
must ﬁrst be converted into ribose-5-phosphate [1]. Hence, it
is of much interest to identify and characterize the enzyme
responsible for this critical ﬁrst step.
The enzyme RK belongs to the PfkB family of carbohydrate
kinases [7], which includes enzymes such as adenosine kinase
(AK), inosine-guanosine kinase, fructokinase, 1-phosphofruc-
tokinase, and 6-phosphofructokinase minor. The overall se-*Corresponding author. Fax: +1 905 522 9033.
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doi:10.1016/j.febslet.2007.06.009quence identity between PfkB family members is less than
30%, but remarkably high structural similarity is seen between
RK [8] and AK [9]. Most of the biochemical and structural
studies on RK have been carried out using enzyme from
E. coli cells [10–12]. Although RK activity was ﬁrst described
in calf liver in 1956 [13], very little work on characterizing this
activity in mammalian systems has been carried out. The iden-
tiﬁcation of the gene encoding for human/eukaryotic RK, or
detailed characterization of this activity in mammalian systems
has not yet been reported. This communication describes, for
the ﬁrst time, deﬁnitive identiﬁcation of the human RK gene
and biochemical characterization of its encoded protein prod-
uct. The substrate speciﬁcity of the enzyme as well as the eﬀects
of a number of activators and inhibitors of human AK on both
human and E. coli RK were studied. Our results indicate that
the catalytic mechanism of both human and E. coli RK is very
similar to that of AK.2. Methods and materials
2.1. Materials
D-[1-3H] ribose (20 Ci/mmol), D-[1-3H] arabinose (20 Ci/mmol),
D-[14C] fructose (300 mCi/mmol), D-[6-3H] galactose (40 Ci/mmol),
and D-[1-3H] xylose (15 Ci/mmol) were purchased from American
Radiolabeled Chemicals (St. Louis, MO). ATP was purchased from
Pharmacia Biotech (Canada). All other chemicals were of analytical re-
agent grade.
2.2. Cloning, expression, and puriﬁcation of E. coli and human RK
The E. coli RK gene (accession no. NC_000913) was ampliﬁed by
PCR from the E. coli genomic DNA using speciﬁc oligonucleotide
primers and cloned into pET22b expression vector. Human RK was
identiﬁed by Blastp searches and its sequence was aligned with that
of E. coli and other ribokinases. For expression of human RK cDNA,
total mRNA from human HT1080 cells was prepared and reverse tran-
scribed using reverse transcriptase. Using this cDNA, the cDNA for
human RK was PCR ampliﬁed using speciﬁc primers based on the pre-
dicted start and end positions of the RK protein. After checking the
sequence for its accuracy, it was cloned into the pET15b expression
vector. For expression studies, the vector constructs were transformed
into E. coli BL21 cells, which were induced with 0.1 mM IPTG for 6 h
at room temperature. The (His)6-tagged protein was puriﬁed to >90%
purity by means of nickel aﬃnity chromatography. Further puriﬁca-
tion was carried out by means of gel-ﬁltration chromatography and
the puriﬁed enzyme was stored at 20 C in 10% glycerol.
2.3. Activity assay
RK activity was measured by a radiochemical method using
D-[1-3H] ribose, as described previously [11]. Assays were performed
at 37 C in 20 mM Tris–maleate buﬀer (pH 7.0) containing 125 mM
KCl. The kinetic data were ﬁtted to the equation:blished by Elsevier B.V. All rights reserved.
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which describes the rate of a bisubstrate reaction where the concentra-
tion of an inhibitory substrate A is varied at a ﬁxed concentration of
the other substrate [14,15]. For the Km determination of ribose, the
concentration of ATP was held ﬁxed at 5 mM, whereas the Km deter-
mination of ATP was carried out in the presence of 2 mM ribose. Sat-
urating concentrations of ribose were avoided in these experiments due
to signiﬁcant enzyme inhibition by the substrate at high concentration.
In all cases, the concentration of free magnesium was ﬁxed at 2 mM,
which produced maximal enzyme activity. Magnesium also showed
inhibitory eﬀects on the enzyme activity at higher concentrations
(not shown).3. Results
3.1. Identiﬁcation of the human RK gene and expression of the
corresponding cDNA
The gene responsible for RK activity and the corresponding
protein has not yet been identiﬁed or biochemically character-
ized in human and other eukaryotic cells. Our Blastp searches
of the NCBI nr database with bacterial (E. coli) RK sequence
identiﬁed a protein in the human genome that has been anno-
tated as ribokinase (protein length 322 aa, accession number
NP_071411){Lander, 2001 276 /id}. Signiﬁcant blast hits with
low E values (<1e25) were also observed for a variety of other
eukaryotic organisms including rat, mouse, dog, chicken, frog,
Drosophila, nematode, Leishmania, Trypanosoma, Entamoeba,
Giardia, various plants (e.g. Arabidopsis thaliana) and fungi
(e.g. Saccharomyces cerevisiae), etc. Interestingly, when Blast
searches were performed with either the human (or mouse)
RK sequence (instead of the E. coli RK sequence), the blast
hits with the lowest E values were for the animal homologs fol-
lowed by those of the bacterial homologs. The hits from plants
and fungi had much higher E values in comparison to the bac-
terial homologs indicating that they were more distantly re-
lated to the human or animal homologs in comparison to
the bacterial proteins.
Table 1 presents a pair-wise sequence identity/similarity ma-
trix of RK sequences from representative prokaryotic and
eukaryotic species. As seen, the human RK shows a muchTable 1
Pair-wise identity/similarity between RK and AK sequences from diﬀerent s
Source of sequence % Identity or similarity in amino acid sequencesa
A B C D E
RK
(A) H. sapiens 69.6 42.8 26.1 29.1
(B) X. tropicalis 81.4 44.1 25.9 27.9
(C) D. melano. 60.9 60.3 26.9 30.6
(D) A. thaliana 41.6 39.3 37.7 28.3
(E) S. cerevisiae 43.4 42.6 44.6 41.5
(F) T. cruzi 56.9 54.5 52.3 39.2 45.8
(G) En. histolytica 55.3 54.7 48.3 40.7 43.5
(H) B. cepacia 50.9 52.7 51.4 41.4 46.4
(I) E. coli 53.2 48.0 48.8 45.7 48.9
(J) H. sapiens 37.8 40.0 40.1 37.4 39.5
AK
(K) A. thaliana 41.1 40.0 41.6 38.1 40.8
(L) S. cerevisiae 41.0 38.7 37.1 40.8 38.0
aSequence alignment and identity/similarity between diﬀerent pairs of sequen
triangles indicate the percent identity and percent similarity, respectively, bet
Arabidopsis; B, Burkholderia; D. melano., Drosophila melangaster; En., Entam
X., Xenopus. RK, ribokinase; AK, adenosine kinase.higher degree of sequence identity to the RK sequences from
protist species (columns F and G) and various bacteria (col-
umns H and I) as compared to that observed for the homologs
from plants and fungi (columns D and E). These results are
unexpected as the fungi and plants are more closely related
to the animals than the bacteria [16]. The human RK also
shows signiﬁcant sequence similarity to the human as well as
other eukaryotic adenosine kinases. However, this sequence
similarity is lower than that seen for any of the ribokinases.
In Fig. 1A, a multiple sequence alignment of RK from some
representative prokaryotic and eukaryotic species is presented.
There are several short stretches that are conserved in all of the
ribokinases, and overall about 12–15% of the residues in diver-
gent species are completely conserved. The human RK gene,
which is located on chromosome 2 (locus NM_022184), is
approximately 110 kb in length and is comprised of 8 exons
of varying lengths (Fig. 1B).
The PfkB family of proteins include many carbohydrate ki-
nases including RK and AK [7]. Based upon the observed se-
quence similarity between E. coli RK and the human protein
(Table 1), one cannot be certain that the human protein in
question corresponds to ribokinase and not some other sugar
kinase. The lower similarity of the human protein to fungi
and plant homologs as compared to bacteria highlights this
problem. To determine whether the protein product of this
putative human gene indeed corresponds to RK, the cDNA
for this gene was PCR ampliﬁed from human HT1080 cells
and expressed in E. coli cells. In cells transformed with the re-
combinant plasmid, a protein of the expected molecular mass
(30 kDa) was expressed at high level upon induction with
IPTG. This protein was puriﬁed to near homogeneity by nick-
el-aﬃnity and gel-ﬁltration chromatography.
3.2. Biochemical characterization of human ribokinase
The protein puriﬁed as outlined above was shown to carry
out eﬃcient phosphorylation of ribose to ribose-5-phosphate
in presence of ATP (under standard conditions containing
2 mM ribose, 5 mM ATP and 10 mM Pi) conﬁrming its iden-
tity as RK. Although ribose metabolism and transport haspecies
F G H I J K L
41.9 37.1 39.1 35.5 21.0 23.5 24.1
39.8 37.1 39.0 31.9 21.7 23.4 22.5
36.2 31.5 39.4 36.0 24.1 26.1 22.9
24.0 26.4 27.4 29.7 21.0 23.3 22.4
28.0 27.4 31.9 30.7 26.9 25.3 22.1
38.7 39.4 36.1 23.5 26.9 23.7
55.0 30.3 31.3 20.7 19.3 21.8
51.5 49.5 42.5 22.0 21.7 27.5
51.8 49.5 55.3 23.2 22.6 20.3
35.9 36.6 34.6 40.1 57.2 39.9
40.2 35.9 37.4 41.2 74.6 39.4
39.4 38.7 40.9 36.9 59.8 55.7
ces were carried out by using the BioEdit program. Upper and lower
ween pairs of sequences. Abbreviations in the sequence names are: A.,
oeba; E., Escherichia; H., Homo; S., Saccharomyces; T., Trypanosoma;
AB
Fig. 1. (A) Sequence alignment of ribokinases from ﬁve species: Homo sapiens, Drosophila melanogaster, Arabidoposis thaliana, Saccharomyces
cerevisiae and E. coli. Symbols: semi-conserved (Æ); conserved (:) and absolutely conserved (*). The asparagine and glutamic acid residues highlighted
in red are part of the conserved NXXE motif (boxed) indicated to be involved in the binding of inorganic phosphate (14). (B) The gene structure of
RK in human. The 8 exons are presented as boxes of corresponding lengths. The total length of the introns not shown here is approximately 108 kb.
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properties of eukaryotic RK have never been studied in detail
in any of the earlier studies. The availability of puriﬁed recom-
binant protein has facilitated examination of its biochemical
properties in detail. Earlier studies on E. coli RK have shown
that its catalytic activity is dependent upon the presence of
phosphate or other pentavalent ions [11]. In the absence of
inorganic phosphate, the bacterial RK enzyme showed only
a low, basal level of catalytic activity, which was greatly stim-
ulated by added phosphate. In the present work, we have ob-
served that the catalytic activity of human RK also showed
marked dependency upon the presence of inorganic phosphate.
Under standard conditions, if Pi was omitted from the reaction
mix, the activity of RK was reduced to <2% of that seen in the
presence of 10 mM Pi (data not shown; see below).
We have subsequently examined the eﬀect of increasing con-
centrations of inorganic phosphate on the steady-state kinetics
of human RK in presence of diﬀerent concentrations of the
two substrates, ribose and ATP. Fig. 2 shows the summary
of the results from this study. As seen, in the absence of Pi,
very little activity is seen at diﬀerent concentrations of the
two substrates. The addition of inorganic phosphate serves
to greatly increase the catalytic activity of the enzyme, as well
as decrease the Km for both substrates, ribose and ATP, in a
concentration-dependent manner (Fig. 2). Increased phos-
phate concentration also correlates with increased Ki values
for both ribose and ATP, suggesting that presence of phos-
phate somehow relieves substrate inhibition of the enzyme
by both substrates (Fig. 2). Decreased Km and increased Ki val-
ues associated with increasing phosphate concentration havebeen also seen in E. coli RK and mammalian AKs previously
[11,17,18].
We have also examined whether the human RK can phos-
phorylate other sugar substrates. Kinetic studies were carried
out and kcat/Km values were calculated to determine the sub-
strate speciﬁcity of the enzyme for other simple sugars includ-
ing D-arabinose, D-fructose, D-galactose and D-xylose. The
results of these studies showed that human RK was highly spe-
ciﬁc for ribose phosphorylation. Besides ribose, very weak
activity was also observed for D-arabinose (kcat/Km, 40.58
and 1.77 s1 mM1, D-ribose and D-arabinose, respectively,
in presence of 10 mM Pi), but no signiﬁcant phosphorylation
was observed of other sugars such as D-fructose, D-galactose
and D-xylose, (kcat/Km; 0.059, 0.08 and 0.15 s
1 mM1, respec-
tively). These results are very similar to those reported recently
for E. coli RK where the phosphorylation eﬃciency of the en-
zyme for D-arabinose, D-fructose and D-xylose was found to
be 0.74%, 1.06% and 0.28%, respectively of that observed for
D-ribose [10].
3.3. Eﬀects of AK activators and inhibitors on human and E. coli
RK
Adenosine kinase and RK are among the few enzymes
known to show phosphate dependency [11]. Earlier studies
on AK have identiﬁed several phosphorylated metabolites
and related compounds, which can either activate AK in place
of inorganic phosphate or inhibit the enzyme in the presence of
phosphate [17,18]. Kinetic and structural studies indicate that
these compounds and inorganic phosphate exert their eﬀects
by acting on the same regulatory site on the enzyme
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Pi (mM) Km (mM) kcat/Km (s-1mM-1) Ki (mM)
1 ( ) 30.43 9.32 0.02 
2 ( ) 6.62 20.85 0.05 
5 ( ) 3.39 31.84 0.13 
10 ( ) 2.17 40.58 0.17 
Pi (mM) Km (mM) kcat/Km (s-1mM-1) Ki (mM)
1 ( ) 0.10 53.59 1.20 
2 ( ) 0.08 63.91 4.40 
5 ( ) 0.07 66.83 18.91 
Fig. 2. Eﬀect of inorganic phosphate on the initial velocity of human RK at varying (A) ribose concentrations and (B) ATP concentrations. The
concentrations of phosphate used were: 0 mM (s); 1 mM (m); 2 mM (.); 5 mM (j) and 10 mM (d). Kinetic parameters in the table were
determined from the plot using the same software. The kinetic parameters at 0 mM phosphate could not be determined reliably due to low enzyme
activity.
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whether AK activators and inhibitors had similar eﬀects on
RK, which presumably shares a similar catalytic mechanism
with AK.
The AK activators whose eﬀect on RK activation was tested
included acetyl phosphate, creatine phosphate, phosphoribosyl
pyrophosphate, dihydroxyacetone phosphate, phosphoenol
pyruvate, and carbamoyl phosphate (refer to [17] for their
chemical structures). All of these compounds caused a dose-
dependent stimulation of the activities of both human and
E. coli RK, although the level of activation was lower then that
seen with inorganic phosphate. The eﬀects of some of these
compounds on activity of the E.coli and human enzymes are
shown in Fig. 3. The degree of stimulation or activation elic-
ited by each compound diﬀered from each other, and also
for the human and E. coli enzymes. As seen in Fig. 3, phos-
phate and AK activators generally produced maximal enzymeA 
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Fig. 3. Eﬀects of various AK activators on the activity of (A) E. coli and (B) h
the absence of any added phosphate, using either (A) E. coli or (B) human R
phosphate (h) and dihydroxyacetone phosphate (s).activity in the concentration range of 5–10 mM, and lead to a
decrease in activity at higher concentrations.
We have also examined the eﬀect of several AK inhibitors on
the activity of E. coli and human RK. The eﬀects of two of these
compounds, phosphonoacetic acid and etidronate, on RK
activity in the presence of 10 mM inorganic phosphate are
shown in Fig. 4. As seen, both these compounds inhibited both
of the enzymes in a similar fashion, with IC50 values in a low
millimolar (1–8 mM) range. The other inhibitors tested (viz.
2-carboxyethylphosphonic acid, N-(phosphonomethyl)-gly-
cine, N-(phosphonomethyl)iminodiacetic acid and clodronate)
also inhibited both E. coli and human RK in a similar manner
as shown previously for the human AK [17]. A subsequent
kinetic study indicates that these compounds inhibit the RK
in a competitive manner with respect to the activating phos-
phate (results not shown), as was found to be the case for
human AK. 
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Fig. 4. Eﬀect of AK inhibitors on (A) E. coli and (B) human RK. Assays were carried out under standard condition in the presence of 10 mM
inorganic phosphate. Symbols: phosphonoacetic acid (–h–) and etidronate (- -- -).
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Currently, there is a great interest in the transport and
metabolism of ribose for its potential as a metabolic supple-
ment. For instance, administration of exogenous ribose accel-
erates the repletion of ATP and helps maintain its level high in
various tissue types [2–4,19]. With these tissue-protective ef-
fects, ribose has potential therapeutic applications involving
the cardiovascular as well as the central and peripheral ner-
vous systems [5,6]. In spite of the importance of ribose metab-
olism, very few studies on ribose metabolism have been carried
out in mammalian cells. Although RK activity was ﬁrst re-
ported in calf liver in 1956 [13], little further work has been
done on characterizing this protein or its various biochemical
properties. The RK gene from any eukaryotic organism has
yet to be deﬁnitively identiﬁed. In this context, it is important
to recognize that because RK belongs to the PfkB family of
carbohydrate kinases [7], mere observance of signiﬁcant simi-
larity between a known bacterial RK and a eukaryotic (viz. hu-
man) gene/protein is not suﬃcient to infer that the latter gene/
protein is RK. The higher degree of similarity of human (or
other animals) RK to the protein from bacteria as compared
to the putative ribokinases from either yeast or plants as seen
in the present work is quite surprising. This result was unex-
pected as plants and fungi are more closely related to the ani-
mals than bacteria [16]. Since the annotation of proteins from
plants and fungi as RK is presently based solely on the ob-
served sequence similarity, it is possible that proteins from
these species may represent some other kinds of sugar kinases
rather than ribokinase. Thus, it is of interest to characterize the
proteins from these species with regard to their substrate spec-
iﬁcities.
In this work, we report for the ﬁrst time deﬁnitive identiﬁca-
tion of the gene for human RK and biochemical characteriza-
tion of its protein product. The human RK protein shows
between 35% and 40% sequence identity to the known bacte-
rial RKs and it eﬃciently catalyzes the conversion of ribose
into ribose-5-phosphate in presence of ATP. Other pentoses
and simple sugars were either not or very poorly phosphory-
lated by the enzyme. The Km of the human RK for ribose
was 10-fold higher than that of the E. coli enzyme, but their
kcat values were comparable [10,11].Human RK, similar to the E. coli enzyme, was also found to
exhibit phosphate dependency, a property that these enzymes
share with the AK, which is also a member of the PfkB family
of proteins [7]. Several phosphorylated compounds, which
have been previously identiﬁed as activators or inhibitors of
AK [11,17,18], also produced similar eﬀects on both the hu-
man, as well as E. coli RK, without a single exception. These
activator and inhibitor compounds have been shown to regu-
late the function of AK by mimicking inorganic phosphate
[11,17,18], and thus are useful tools to identify other phos-
phate-dependent enzymes. These results, along with the similar
eﬀects of the phosphate on the catalytic activity and Km for the
sugar-derived substrates for AK and RK, provide evidence
that these two enzymes share a similar catalytic mechanism,
in common with some other phosphate-dependent enzymes
[11,14,17,20,21].
The structure of E. coli RK has been solved with a bound
phosphate, as well as ribose and ADP [8]. This phosphate ion
makes close contacts with asparagine and glutamic acid res-
idues at sequence positions 187 and 190, whose correspond-
ing residues are also conserved in the human form (see
boxed in Fig. 1A). In earlier studies, we have shown that
these amino acid residues, forming an NXXE sequence motif,
are also completely conserved in other proteins belonging to
the PfkB family of carbohydrate kinases [14]. Site-directed
mutagenesis of these conserved residues in Chinese hamster
AK has led to proteins with greatly altered phosphate stimu-
lation and substrate inhibition characteristics [14]. Recently,
site-directed mutation of the NXXE motif in E. coli phos-
phofructokinase-2 (also a member of the PfkB family) led
to creation of mutant enzymes with altered MgATP2+ and
phosphate requirements [22]. Therefore, the sequence motif
NXXE may represent the site of phosphate binding and acti-
vation for AK, RK, Pfk-2, as well as other enzymes belong-
ing to the PfkB family of carbohydrate kinases. The
identiﬁcation and characterization of human RK as described
in this work sets the stage for understanding the function of
this enzyme in ribose metabolism and cell structure and func-
tion.Acknowledgement: This work was supported by the Research Grant
T-4688 from the Heart and Stroke Foundation of Ontario.
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